10/13
08:07 am
abeo
Abeona Therapeutics (NASDAQ:ABEO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Abeona Therapeutics (NASDAQ:ABEO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.